GLP Medication and Muscle Loss: What Nobody Is Telling You

Ozempic. Wegovy. Mounjaro. If you haven't heard these names yet, you will. GLP-1 receptor agonists have gone from diabetes clinics to dinner table conversations in the space of two years. One in eight Americans is now taking one. In the UK, prescriptions are rising fast. These drugs work — there's no question about that. For people living with obesity, they represent a genuine breakthrough.

But here's what the headlines miss.

Weight loss is not the same as fat loss. And if you're on a GLP-1 medication — or thinking about it — there is a conversation you need to have with a fitness professional before you lose something you can't easily get back.

Muscle.

What Are GLP-1 Medications, and How Do They Work?

GLP-1 stands for glucagon-like peptide-1. It's a hormone your gut releases naturally after eating. It tells your pancreas to produce insulin, slows digestion, and signals your brain that you're full. GLP-1 receptor agonists — drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) — mimic and amplify this effect.

The result: reduced appetite, lower calorie intake, and significant weight loss. Clinical trials show people losing 15–20% of their body weight over 68 weeks. For context, that's more than double what any previous obesity medication achieved.

They're not magic. They're pharmacology doing exactly what pharmacology is supposed to do — giving the body a push it couldn't manage on its own. There's no shame in that. But they come with a side effect that doesn't make the adverts.

The Muscle Loss Problem

When your body loses weight — through any means — it doesn't only burn fat. It burns muscle too. This is a basic physiological fact. On a calorie deficit, your body will pull energy from lean tissue as well as fat stores. GLP-1 medications create a significant calorie deficit by suppressing appetite, which is exactly why they work. But that same mechanism puts your muscle mass at risk.

Research published in major journals has shown that without intentional resistance training and adequate protein intake, somewhere between 25–40% of weight lost on GLP-1 therapy can come from lean mass rather than fat. That's not a minor side effect. That's potentially a quarter of every kilo you lose being muscle you needed.

The latest research — including a large genetic analysis of over 800,000 individuals — offers some reassurance: fat mass reduction does outpace lean mass reduction. And a 2026 study found that skeletal muscle loss is less severe than earlier data suggested, with a significant portion of lean mass reduction actually coming from organs like the liver rather than skeletal muscle. That's good news. But it doesn't mean the risk disappears.

The ACE's 2025 review is clear: even though GLP-1 drugs favour fat loss, the concurrent reduction in muscle mass cannot be ignored. Health professionals should prioritise resistance training and progressive overload in clients on these medications.

The science is landing in one direction: resistance training isn't optional for people on GLP-1 medications. It's the intervention.

Why Muscle Mass Matters More Than the Number on the Scale

Most people define weight loss success by what the scales say. But the scales don't tell you what you're made of. Muscle mass is not cosmetic, It is metabolic currency.

Muscle is metabolically active tissue. It burns calories at rest. Lose it, and your basal metabolic rate drops. That means the moment you stop or reduce the medication — and most people do within a year — your body is burning fewer calories than before, even if you weigh less. This is the rebound trap. It's not a failure of willpower. It's physiology.

Your strength and function

Muscle mass directly determines how capable you are in daily life — carrying shopping, climbing stairs, getting up from the floor. For people over 40, this is not a gym conversation. It's an independence conversation. Sarcopenia — age-related muscle loss — already accelerates from your mid-30s. Stack GLP-1-induced muscle loss on top of that, and you're fast-tracking a problem that most people don't notice until it's a significant issue.

Your bone density

Muscle and bone are mechanically linked. The forces generated by muscle during resistance training stimulate bone remodelling. Less muscle activity means less mechanical load on bone. For women approaching or in menopause — a population increasingly taking GLP-1 medications — this intersection of risks deserves serious attention.

What the Research Says You Should Do

The evidence is consistent across multiple studies and institutional guidelines. Combining GLP-1 receptor agonists with structured lifestyle changes — specifically increased protein intake and resistance training — can significantly mitigate muscle loss and substantially improve overall outcomes.

Research presented at the European Congress on Obesity in 2025 confirmed that adults on GLP-1 medications were able to retain muscle while losing weight when they prioritised strength training and adequate protein. This isn't theoretical. It's been demonstrated.

Resistance training: 2–3 sessions per week, non-negotiable

The programming should prioritise multi-joint movements — squats, deadlifts, pressing, pulling. These recruit the most muscle mass and deliver the most stimulus for preservation and growth. Progressive overload — gradually increasing the challenge over time — is the mechanism. You cannot preserve muscle by accident.

Protein: 1.2–2.0g per kilogram of bodyweight daily

This is the recommendation from exercise physiology guidelines. GLP-1 medications suppress appetite, which means many users are eating significantly less — and often not enough protein. Protein is the raw material for muscle repair and maintenance. If your appetite is suppressed and you're not being deliberate about protein intake, your muscles will pay the price. Aim for a minimum of 1.6g/kg if you're training. Distribute it across meals rather than front-loading it.

Recovery: it matters even more when you're in a deficit

Reduced calorie intake means reduced energy for recovery. Sleep quality, training frequency, and deload weeks all become more important, not less. GLP-1 users may be deconditioned at the start of their journey — programming needs to account for that and build progressively.

The Role of a Personal Trainer: More Critical Than Ever

The fitness industry is catching up to this conversation, but slowly. A lot of people on GLP-1 medications are losing weight and celebrating the number on the scales — without anyone telling them about what they might be losing underneath.

This is exactly where the personal trainer's role has evolved. As the National Academy of Sports Medicine (NASM) identified in their 2026 industry survey, the widespread use of GLP-1 medications has elevated the trainer's role in muscle preservation, strength training, and metabolic support — shifting the conversation away from calorie-burn-centric coaching.

If you're a client on a GLP-1 medication, your trainer needs to understand:

— Your likely reduced energy levels and recovery capacity

— The critical importance of progressive resistance training

— Protein targets and how to hit them even with suppressed appetite

— How to track body composition changes, not just body weight

— The long-term plan for when the medication ends

My Take — From Both Sides of the Fence

As an anaesthetic nurse, I've seen the clinical side of obesity management. I understand the disease burden, the co-morbidities, the genuine complexity of treating it. GLP-1 medications are a legitimate and valuable tool in that landscape. I'm not here to talk anyone out of a medically appropriate treatment.

As a personal trainer, I see what happens when people chase weight loss without thinking about body composition. The number goes down. The muscle goes with it. The metabolism slows. The results don't last.

The answer isn't to avoid the medication. The answer is to protect your lean mass while it's doing its job — and build a foundation of strength that outlasts the prescription.

Lift. Eat protein. Train progressively. That's not a trend. That's the physiology.

If you're on a GLP-1 medication and want to build a training programme that protects your muscle mass, get in touch. This is exactly what I do.